16 May 2018 
NDF identified as the missing factor in gene activation
16 May 2018 | By Drug Target Review
Scientists find the missing factor in gene activation...
List view / Grid view
News
16 May 2018 
SB216763 shows preclinical efficacy in Rett syndrome
16 May 2018 | By Drug Target Review
Researchers describe how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome...
16 May 2018 
mEAK-7 gene could suggest path towards cancer therapies
16 May 2018 | By Drug Target Review
Researchers have found mEAK-7 regulates the molecular process that dictates cell growth and human development...
15 May 2018 
A link between Huntington’s disease and rheumatoid arthritis identified
15 May 2018 | By Dr Zara Kassam (Drug Target Review)
Epigenomic analyses may lead to other unexpected findings and novel therapeutic drug targets for many diseases
15 May 2018 
Tumour-like spheres help scientists discover smarter cancer drugs
15 May 2018 | By Drug Target Review
Researchers are reporting an innovative new method to screen for potential cancer drugs...
15 May 2018 
Elastic microspheres expand understanding of embryonic development and cancer cells
15 May 2018 | By Drug Target Review
A new technique that uses tiny elastic balls filled with fluorescent nanoparticles aims to expand the understanding of the mechanical forces that exist between cells...
14 May 2018 
Scientists screen molecules for new prostate cancer drugs
14 May 2018 | By Drug Target Review
Cancer researchers have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers...
14 May 2018 
CRISPR used to restore retinal function
14 May 2018 | By Dr Zara Kassam (Drug Target Review)
Researchers have developed a new technique to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa...
14 May 2018 
New biomarker identified for early diagnosis of lung cancer
14 May 2018 | By Drug Target Review
High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.
11 May 2018 
Scientists overcome cell rejection in neuron replacement treatment for spinal cord injuries
11 May 2018 | By Drug Target Review
Scientists have successfully overcome the persistent cell rejection that has hitherto plagued attempts to introduce neural stem cells to replace damaged tissue in pigs.
11 May 2018 
Lab-on-a-chip device mimics eye damage due to intense light
11 May 2018 | By Dr Zara Kassam (Drug Target Review)
Researchers create eye neuron network model to study retinal diseases, possible treatment options...
10 May 2018 
Targeting cPLA2 may improve the treatment of epilepsy
10 May 2018 | By Drug Target Review
New findings demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy...
10 May 2018 
Diverse Parkinson’s-related disorders may stem from different strains of same protein
10 May 2018 | By Drug Target Review
Researchers found that the type of brain cell afflicted in Parkinson’s-related brain disorders dictates which pathological form of α-synuclein (α-syn) protein becomes the disease culprit.
10 May 2018 
CKAP4 biomarker identifies stage I lung cancer
10 May 2018 | By Drug Target Review
Scientists in Japan have discovered a promising new biomarker – cytoskeleton-associated protein 4 (CKAP4) – for lung cancer, potentially transforming the way the disease is diagnosed and treated.
9 May 2018 
Cellular reprogramming promotes muscle regeneration in injured mice
9 May 2018 | By Drug Target Review
Scientists have developed a simple and robust approach for directly reprogramming mature skin cells into immature muscle cells...
Follow: